VRS
AVDL

Virginia Retirement Systems’s Avadel Pharmaceuticals AVDL Stock Holding History

Virginia Retirement Systems’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,900
Closed -$176K – 937
2025
Q2 		$176K Buy
19,900
+2,400
+14% +$21.1K ﹤0.01% 908
2025
Q1 		$137K Buy
+17,500
New +$147K ﹤0.01% 988

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

Virginia Retirement Systems's AVDL Position: Q3 2025 in Review

Virginia Retirement Systems sold out of Avadel Pharmaceuticals (AVDL) in Q3 2025, closing a stake of 19,900 shares — an estimated $176K sold.

Virginia Retirement Systems first reported a position in AVDL in Q1 2025 and held it in 2 quarters. The position peaked at $176K in Q2 2025. 188 funds tracked by Wall St. Rank hold AVDL as of Q3 2025.

  • Virginia Retirement Systems reported no remaining Avadel Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Virginia Retirement Systems sold 19,900 Avadel Pharmaceuticals shares in Q3 2025, an estimated $176K.
  • Virginia Retirement Systems first reported a position in Avadel Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • Virginia Retirement Systems's Avadel Pharmaceuticals position peaked at $176K in Q2 2025.
  • 188 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2025.

Based on Virginia Retirement Systems's 13F filing for Q3 2025, filed 20 Oct 2025.